Researchers concluded that the GLP-1RA showed no ability to slow disease progression in people living with Parkinson’s ...
University of Tasmania and Parkinson's Research Foundation bridge gap in Parkinson's knowledge with first of its kind resourceFree online course ...
The singer-songwriter gained recognition from the Recording Academy in the early 1990s, winning the Grammy for Best New ...
The U.S. Food and Drug Administration has approved Supernus Pharmaceuticals' drug-device combination to treat ...
The GLP-1 drug, exenatide, has no positive impact on the movement, symptoms or brain imaging of people with Parkinson's, ...
Supernus Pharmaceuticals has won US approval for its wearable pump Onapgo (apomorphine hydrochloride) to treat symptoms of ...
Popular singer Marc Cohn took to social media Thursday to share some heartbreaking health news.
The market for Parkinson’s disease (PD) drugs across the seven major geographies (7MM; USA, France, Germany, Italy, UK and ...
Researchers have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and FDA-approved drugs that ...
News Medical on MSN10d
AI technology uncovers genetic factors and treatment options for Parkinson'sResearchers from the Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and ...
Three strikes and you’re out? Not for Supernus Pharmaceuticals and its Parkinson’s disease infusion pump. | The device is ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback